Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2

FASEB Journal

Volumn 19, Issue 2, 2005, Pages 249-251

  Kilic, Ülkan ^a,c   Kilic, Ertugrul ^a   Soliz, Jorge ^b   Bassetti, Claudio L ^a   Gassmann, Max ^b   Hermann, Dirk M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CASPASE 3; ERYTHROPOIETIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BCL XL; PROTEIN KINASE B; STAT5 PROTEIN; WORTMANNIN;

ANIMAL MODEL; ARTICLE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MOUSE; NERVE FIBER TRANSECTION; NEUROPROTECTION; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RETINA DEGENERATION; RETINA GANGLION CELL; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 13244252517     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.04-2493fje     Document Type: Article

References (29)

1. Gassmann, M., Heinicke, K., Soliz, J., and Ogunshola, O. O. (2003) Nonerythroid functions of erythropoietin. Adv. Exp. Med. Biol. 543, 323–330
2. Brines, M. L., Ghezzi, P., Keenan, S., Agnello, D., de Lanerolle, N. C., Cerami, C., Itri, L. M., and Cerami, A. (2000) Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. USA 97, 10526–10531
3. Sirén, A. L., Fratelli, M., Brines, M., Goemans, C., Casagrande, S., Lewczuk, P., Keenan, S., Gleiter, C., Pasquali, C., Capobianco, A., et al. (2001) Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl. Acad. Sci. USA 98, 4044–4049
4. Grimm, C., Wenzel, A., Groszer, M., Mayser, H., Seeliger, M., Samardzija, M., Bauer, C., Gassmann, M., and Reme, C. E. (2002) HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat. Med. 8, 718–724
5. Ehrenreich, H., Hasselblatt, M., Dembowski, C., Cepek, L., Lewczuk, P., Stiefel, M., Rustenbeck, H. H., Breiter, N., Jacob, S., Knerlich, F., et al. (2002) Erythropoietin therapy for acute stroke is both safe and beneficial. Mol. Med. 8, 495–505
6. Hudson, J. Q., and Sameri, R. M. (2002) DarbEpoetin alfa, a new therapy for the management of anemia of chronic kidney disease. Pharmacotherapy 22, 141S–149S
7. Macdougall, I. C. (2003) Erythropoietin and renal failure. Curr. Hematol. Rep. 2, 459–464
8. Chong, Z. Z., Kang, J. Q., and Maiese, K. (2002) Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades. J. Cereb. Blood Flow Metab. 22, 503–514
9. Chong, Z. Z., Lin, S. H., Kang, J. Q., and Maiese, K. (2003) Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8. J. Neurosci. Res. 71, 659–669
10. Nagata, Y., Takahashi, N., Davis, R. J., and Todokoro, K. (1998) Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation. Blood 92, 1859–1869
11. Jacobs-Helber, S. M., Ryan, J. J., and Sawyer, S. T. (2000) JNK and p38 are activated by erythropoietin (Epo) but are not induced in apoptosis following Epo withdrawal in Epodependent HCD57 cells. Blood 96, 933–940
12. Ihle, J. N. (1995) Cytokine receptor signalling. Nature 377, 591–594
13. Chong, Z. Z., Kang, J. Q., and Maiese, K. (2003) Apaf-1, Bcl-xL, cytochrome c, and caspase-9 form the critical elements for cerebral vascular protection by erythropoietin. J. Cereb. Blood Flow Metab. 23, 320–330
14. Ruschitzka, F. T., Wenger, R. H., Stallmach, T., Quaschning, T., de Wit, C., Wagner, K., Labugger, R., Kelm, M., Noll, G., Rülicke, T., et al. (2000) Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proc. Natl. Acad. Sci. USA 97, 11609–11613
15. Wiessner, C., Allegrini, P. R., Ekatodramis, D., Jewell, U. R., Stallmach, T., and Gassmann, M. (2001) Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin. J. Cereb. Blood Flow Metab. 21, 857–864
16. Garcia-Valenzuela, E., Gorczyca, W., Darzynkiewicz, Z., and Sharma, S. C. (1994) Apoptosis in adult retinal ganglion cells after axotomy. J. Neurobiol. 25, 431–438
17. Isenmann, S., Wahl, C., Krajewski, S., Reed, J. C., and Bähr, M. (1997) Up-regulation of Bax protein in degenerating retinal ganglion cells precedes apoptotic cell death after optic nerve lesion in the rat. Eur. J. Neurosci. 9, 1763–1772
18. Kilic, E., Hermann, D. M., Isenmann, S., and Bähr, M. (2002) Effects of pinealectomy and melatonin on the retrograde degeneration of retinal ganglion cells in a novel model of intraorbital optic nerve transection. J. Pineal Res. 32, 106–111
19. Kilic, Ü., Kilic, E., Dietz, G. P. H., and Bähr, M. (2004) The TAT protein tranduction domain enhances the neuroprotective effect of glial cell line-derived neurotrophic factor after optic nerve transection. Neurodegen. Dis. 1, 44–49
20. Klöcker, N., Kermer, P., Weishaupt, J. H., Labes, M., Ankerhold, R., and Bähr, M. (2000) Brain-derived neurotrophic factor-mediated neuroprotection of adult rat retinal ganglion cells in vivo does not exclusively depend on phosphatidyl-inositol-3'-kinase/protein kinase B signalling. J. Neurosci. 20, 6962–6967
21. Kermer, P., Klöcker, N., Labes, M., and Bähr, M. (2000) Insulin-like growth factor-I protects axotomized rat retinal ganglion cells from secondary death via PI3-K-dependent Akt phosphorylation and inhibition of caspase-3 in vivo. J. Neurosci. 20, 2–8
22. Wenger, R. H., Marti, H. H., Bauer, C., and Gassmann, M. (1998) Optimal erythropoietin expression in human hepatoma cell lines requires activation of multiple signalling pathways. Int. J. Mol. Med. 2, 317–324
23. Digicaylioglu, M., Bichet, S., Marti, H. H., Wenger, R. H., Rivas, L. A., Bauer, C., and Gassmann, M. (1995) Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc. Natl. Acad. Sci. USA 92, 3717–3720
24. Marti, H. H., Wenger, R. H., Rivas, L. A., Straumann, U., Digicaylioglu, M., Henn, V., Yonekawa, Y., Bauer, C., and Gassmann, M. (1996) Erythropoietin gene expression in human, monkey and murine brain. Eur. J. Neurosci. 8, 666–676
25. Höpfl, G., Ogunshola, O., and Gassmann, M. (2004) HIFs and tumors - causes and consequences. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R608–R623
26. Joneja, B., and Wojchowski, D. M. (1997) Mitogenic signalling and inhibition of apoptosis via the erythropoietin receptor Box-1 domain. J. Biol. Chem. 272, 11176–11184
27. Zhuang, H., Niu, Z., He, T. C., Patel, S. V., and Wojchowski, D. M. (1995) Erythropoietindependent inhibition of apoptosis is supported by carboxyl-truncated receptor forms and blocked by dominant-negative forms of Jak2. J. Biol. Chem. 270, 14500–14504
28. Digicaylioglu, M., and Lipton, S. A. (2001) Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412, 641–647
29. Leist, M., Ghezzi, P., Grasso, G., Bianchi, R., Villa, P., Fratelli, M., Savino, C., Bianchi, M., Nielsen, J., Gerwien, J., et al. (2004) Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305, 239–242